{"name":"Halozyme Therapeutics","slug":"halozyme-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Chemophase","genericName":"Chemophase","slug":"chemophase","indication":"Other","status":"phase_1"},{"name":"large protein molecule","genericName":"large protein molecule","slug":"large-protein-molecule","indication":"Other","status":"marketed"},{"name":"recombinant human hyaluronidase","genericName":"recombinant human hyaluronidase","slug":"recombinant-human-hyaluronidase","indication":"Other","status":"marketed"},{"name":"recombinant human hyaluronidase PH20","genericName":"recombinant human hyaluronidase PH20","slug":"recombinant-human-hyaluronidase-ph20","indication":"Other","status":"marketed"},{"name":"regular human insulin","genericName":"regular human insulin","slug":"regular-human-insulin","indication":"Other","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Humalog","genericName":"Humalog","slug":"humalog","indication":"Diabetes mellitus type 1","status":"marketed"}]}],"pipeline":[{"name":"Chemophase","genericName":"Chemophase","slug":"chemophase","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Humalog","genericName":"Humalog","slug":"humalog","phase":"marketed","mechanism":"Insulin receptor","indications":["Diabetes mellitus type 1","Diabetes mellitus type 2"],"catalyst":""},{"name":"large protein molecule","genericName":"large protein molecule","slug":"large-protein-molecule","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"recombinant human hyaluronidase","genericName":"recombinant human hyaluronidase","slug":"recombinant-human-hyaluronidase","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"recombinant human hyaluronidase PH20","genericName":"recombinant human hyaluronidase PH20","slug":"recombinant-human-hyaluronidase-ph20","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"regular human insulin","genericName":"regular human insulin","slug":"regular-human-insulin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOQndHZ2psTWVUNFJxOFd0TzdCTmRRUGh4am90RXhNQXRXMEVJbWxzTVRhWFdpTzlsMkc1WTd0X1JxNVdPemd1TDBUa0pjM0h4UnR0RmhtbGk2Uk5sSE1ZQ1BWNlRlVEpMazhwV25iRHVTNy1mMThxUmVBblp4TFlZZVduUnluYlV6VlJ4NzVQQ1ppWVZhYlJZdTVPcWZGanF4a3VQTjllUGprdTk0MEZiZlFlb1RUbE5CS2VwbWtmaXpzUThieWlwQWJPNjQyRHkxQk92S1RqamtYVGNoZmcwNS1QTjNoRXItTHNvM3hkYjFUU2ZLQm9nZmhldmlYZw?oc=5","date":"2026-04-07","type":"deal","source":"PR Newswire","summary":"Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology - PR Newswire","headline":"Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQUGlPVGJxTDlWQWF4ZDZKX3BhSmRtZ1luWTUzSUxCSlkzem1hVkJISTZ0WTFXX1UtY005bWMxRmgzUG5KSTlIVWRtWm03ZG1SYVVZelVINlVnTEg4enp4T1NlVlRGR1cxdkMtbnJXU05wLTR1VFFhVVZ4OFIxVnFUVjhTRE9GUlFsSWlZVXg4a3NJTXRJSThfTDQyd2RUNi15OXgwRVhlaUdLbDZIVG9OZWNReXRxNkFMbC02YQ?oc=5","date":"2026-04-07","type":"deal","source":"fiercepharma.com","summary":"Vertex taps Halozyme and its recently acquired Elektrofi tech in $15M drug delivery deal - fiercepharma.com","headline":"Vertex taps Halozyme and its recently acquired Elektrofi tech in $15M drug delivery deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOandNS0RMRjdHUkEzNjZ0N0o4bVN1S2NHMFNpTExEcmR2UFp5bnFSbi1kQ1h1M0hGZzNuRDEwNGNadkZSVG9CS2taMWdteHBDVGJvMmtGVGpqelowZ1ZzRlhUeTBEaWtmekg0aHQyTkpTWEZfQUQ4MFlsQmhzN3JmTkppTVNma1RfTG83ZGNNRk5OeFBxYVF3a1pybzlNNExPSy1makQ4SHJBVlc2VkE4Z2J5NFBzOHZkV3pSZ0dBZzdhNzNuamc?oc=5","date":"2026-04-07","type":"deal","source":"Contract Pharma","summary":"Halozyme, Vertex Pharmaceuticals Enter Exclusive Collab & License Agreement - Contract Pharma","headline":"Halozyme, Vertex Pharmaceuticals Enter Exclusive Collab & License Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5wWHU3c2hTVEdDRC1XcGtTUXpvUElCX0tMVHBaWXViRjBwTDYxSDRnNHM2Tnpod2hGN2Rza3NZcmJET2lPSVF0QnJoblRZSDIwRG1KNEtQMzZVcUN5UFpiYkhXWkdfTnpLMGJDUUxmZWRBUG05OFVOQXFlRllqZmc?oc=5","date":"2026-04-07","type":"pipeline","source":"seekingalpha.com","summary":"Vertex Pharma in pact with Halozyme for Hypercon (VRTX:NASDAQ) - seekingalpha.com","headline":"Vertex Pharma in pact with Halozyme for Hypercon (VRTX:NASDAQ)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPajIyRVdFaUZkX2s2OW8zVnRVV0J0U00wVnM1WXVnQ2UzVF9xRFVGSmlVckNDTl8zSFNRLWpVcUh3cF9ZR3Jvbk1mRGtBd0ptbkRVcUFrdkhUNExoREdka1JGQWxTYml5bUFHUWxQRHRqSGZGVjV4ZkY2ZHlaQm5GdUhvWXZPeHNfOGhoQXlYZHVxT3FPdGF6OTM4T01MV2hiWkptb1dhMm9IdzltcjJpUUZGNkRGNU0?oc=5","date":"2026-04-07","type":"deal","source":"Moomoo","summary":"Halozyme Unit Enters License Deal With Vertex Pharmaceuticals for Hypercon Technology - Moomoo","headline":"Halozyme Unit Enters License Deal With Vertex Pharmaceuticals for Hypercon Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPaGcwdnNjczNHb0NnMVZRNm5SRHpvdkowRzlDZnFSajBydUIyRmlELVdVc3RNWkIwUFdMUVlZWWdPZVQycU5GdjRnRjZXVzlRTFRUaG9Ddm96UDZZall5R0lkeUZIQjRXcEtyS0U0cVNBZWx1UkJoY1hPQ1FKdUstQkFlNGplbHpMQ0hVek95NTZ1ZTVDX0h5Y0F5dFdiblAzbDBXbEdEc2lOcldrLU1ERkMxVHBzS295WVN0N1VqdW9SVzdNMDJmdy0ySng5ZjRxRlJ4UlZZQ2lrcDI3cmFYZS1saWVLOXNK?oc=5","date":"2026-04-07","type":"deal","source":"marketscreener.com","summary":"Halozyme announces global collaboration and license agreement with Vertex Pharmaceuticals for Hypercon(TM) technology - marketscreener.com","headline":"Halozyme announces global collaboration and license agreement with Vertex Pharmaceuticals for Hypercon(TM) technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOR0JYbUdmdUtpa2EzQUpSRjZYcTAxZmNrSHUwczJCakU4d0ZBN0d3dm5PczJDNENsTzBVQzhmNWtUSmo1ZG1SOXFPTmhURkNCTFpzRXhNQnBaR2Qxd0RwUjN4ZE92TGF3bTdaN1pvN1J0UkZwVHBNOHRWblNpSk04TFBpdWNpRVAwbHdzeWJEY29oMlVtUlZyQUNxbVgyWFNQc2pRS2s4N0tSbUNDYjY4V2FKMjlkUDJsVzJkOW11TkVGckFY?oc=5","date":"2026-04-07","type":"deal","source":"AD HOC NEWS","summary":"Vertex Pharmaceuticals Inc stock: New Halozyme deal signals pipeline push - AD HOC NEWS","headline":"Vertex Pharmaceuticals Inc stock: New Halozyme deal signals pipeline push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPVWZaekFQcDVCeUM5cmxLRGZrS1oya09IZ0JQeFVlMkV3YTlvMVlPcENRZk93RlJFT2VBMUJkeGMwWENCZkdPcTFYSVF0UjlMYi12b3dtOXZhd2d0VFVlOEllNTl1Mm94Vlg1TWlEOEx5MXlfUTNQTlJUXzhEQW5fb0huVQ?oc=5","date":"2026-01-28","type":"deal","source":"pharmaphorum","summary":"Halozyme diversifies in drug delivery with Surf Bio buy - pharmaphorum","headline":"Halozyme diversifies in drug delivery with Surf Bio buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSS1CRlJmNzl2OE5hU3luLVE1cF9tZ1FSazVCdHlVb0RpaDJ4azJfdXpCWnJqV0FRVUMzaUxteWJ1VzNmMndLcm1ic1hHTTc2VWlZRFB3LWk2cWx6ODdXN0ZONGNfNXFpMG1OUGdfSUxjdTFYZWZvQ2ZzU3Zqa2ozVzctS3ozTlo3M1hqdmxYM2NQNndwbHZXUQ?oc=5","date":"2026-01-24","type":"pipeline","source":"The Motley Fool","summary":"2 Under-the-Radar Biotech Stocks Set to Boom in 2026 - The Motley Fool","headline":"2 Under-the-Radar Biotech Stocks Set to Boom in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNaEFZYnRrZFFBOUpQVjFGc2w3R0oyM2VTV2hoSE5hUU5uM1gyX2R0ZWxQNFRlcHVHc21uQXo0V3RuR2sxTVN5NjRLUFpPTWlJaWxjNUMxSmdFYnUwZ2Y4R194WHZyMzFXRTNqZExYRXJMTVZXWVBvVExLeGVZaDJSbWhrRElOLVZ6amVxUE9SYkM2NmVoU1BTSTFWZUZaQ1dMaVlGUXliOHI?oc=5","date":"2025-10-14","type":"deal","source":"fiercepharma.com","summary":"Halozyme CEO targets new deals as IRA uncertainty subsides - fiercepharma.com","headline":"Halozyme CEO targets new deals as IRA uncertainty subsides","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPN2pPM29MYWUtTC0yOHVnMEhxN0tmRGVUT1h3dm1UTmhtcFZ1em5rMG1HcGEtTmVGdXloSWRfM01sRF96VkI5TkpzR0ZNbnZQa3VqOU93dlhDa0NIWF9iNHpBSTBUTUIwVHBfb0ZpazZXby1JVFhYTl9YcFREZzZ1ZEhEdTJuNWRmWWJLaDNSME9VdDJKdTNrU0RtekJjNjBxYkkxN0M4WVU?oc=5","date":"2025-10-02","type":"deal","source":"BioSpace","summary":"Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together - BioSpace","headline":"Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1rQmhTcHdseXBiSDhadVY2SjJGemJMaE1yS3VCeGhNNllMUGg2Q1NiZEtqajN2SDNEMkpoR3FRM0hOOXVCS3dCZ1hDVWVobUpPaTRV?oc=5","date":"2025-10-01","type":"deal","source":"FirstWord Pharma","summary":"Halozyme to add Elektrofi's drug-delivery tech via $750M deal - FirstWord Pharma","headline":"Halozyme to add Elektrofi's drug-delivery tech via $750M deal","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_1":1,"marketed":5},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}